about
ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural OverviewProteolytic processing of von Willebrand factor by adamts13 and leukocyte proteasesPrognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.Attack of the acronyms: TTP, VWF, ADAMTS-13 and SELDI-TOF-MS.A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry.Thrombotic thrombocytopenic purpura and its diagnosis.Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura.Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.Systemic antithrombotic effects of ADAMTS13.A new tool to further explore the role of ADAMTS-13 in health and disease.New-onset and idiopathic thrombotic thrombocytopenic purpura: incidence, diagnostic validity, and potential risk factors.Outcomes in the treatment of thrombotic thrombocytopenic purpura with splenectomy: a retrospective cohort study.Thrombotic thrombocytopenic purpura mimicking acute ischemic stroke.Management of cancer-associated thrombotic microangiopathy: what is the right approach?Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.Journey in reverse: TTP from bedside to blood bank to bench.Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.Thrombotic microangiopathies: an update.Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura.Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005.The role of von Willebrand factor in hemorrhagic and thrombotic disorders.Thrombotic thrombocytopenic purpura induced by metronidazole vaginal gel.Thrombotic thrombocytopenic purpura in childhood: an uncommon but life-threatening cause of thrombocytopenia.Thrombotic thrombocytopenic purpura-like thrombocytopenia closely related to uremia: report of two cases.Rituximab in the treatment of autoimmune haematological disorders.Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.Rituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literature.Thrombocytopenias: a clinical point of view.The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission.A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infectionA 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndromeEscherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Rapid identification of thrombocytopenia-associated multiple organ failure using red blood cell parameters and a volume/hemoglobin concentration cytogram.Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature.Indicators of acute and persistent renal damage in adult thrombotic microangiopathy.Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.Endothelial cells and thrombotic microangiopathy.ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura.
P2860
Q26747656-8AE3C97A-9FFF-47CD-9742-CB7527995028Q26827966-3CFD173A-B4F5-45FC-8CDF-6E8C4AC28C85Q31077457-1D9AF2CD-55EC-488D-9912-ADFED0FA4112Q33231921-51BCFD78-0978-4D09-A095-513FAE5C01FAQ33231922-D5499300-F647-4553-A20F-564A53B1F970Q33366296-BFEA66EF-18B0-4FBB-9FCD-14137210BDBCQ33369692-6F54E09C-434C-4BDE-B193-B6E439B7BD98Q33369765-028ECC91-DF20-4BC2-BD5D-244D01885FC5Q33370540-99CAF5C8-6151-4F3F-9877-B03B5708496FQ33371176-9CABF65C-F6C1-448C-A84F-B4D012D61B36Q33371686-C9E77834-931E-4CCB-8D33-AF09D1D5963EQ33372156-B1F267CC-02DF-4BB8-B3A2-518E021CECF0Q33372320-012C17F8-58BF-41F8-9C5D-5668E5EF21FCQ33372938-975EEA00-EC38-4982-8EB2-F075C7E8276AQ33372953-89AC2DDB-19F1-4DC3-A639-656ECC97F1FAQ33373368-30D48ED4-E2A6-4DFE-8D69-6AA4FE3B89B0Q33374172-3F12AEF6-18E0-471D-8165-F586FBEA356BQ33374294-8E12E938-B0D2-4D72-895F-17C5B864CB46Q33374370-F17D0545-9F2C-41E6-8AB1-388243780695Q33374400-7B7322A9-FF1D-4347-BA61-BA81814A6F2DQ33374424-A6388B56-0EF1-4F6A-875B-D72F9C3D7675Q33374578-AB27F643-6D02-4A76-8F3D-BE0F8070AC01Q33375696-6C78A11D-DCB4-44E8-99C9-782702C4B773Q33376197-3AFA100B-D4D2-4900-B87A-2AFAF6599BCDQ33376612-36F55428-9E90-44B4-9383-84A3BB56A1B4Q33378854-4F6F9A9A-8B50-49FA-875E-CAD2BF49008EQ33380771-6BE155B8-FF41-4009-BF0A-B86F90288F38Q33380812-9008E522-FC92-44B6-8D96-8FB24255DB3FQ33384884-ABBB3FE0-02D1-4861-B564-0E4405EF214CQ33385105-3FE0DE33-A94C-422E-8237-E3C03DBDEF7AQ33386423-B15A1B2B-7DA9-4FD1-A6EC-00B63E694C07Q33388071-037C2F83-72E8-4763-9523-C29FDF149DE4Q33391086-73640EF0-3A48-4D9A-8FEF-AFC28D8E6C1CQ33394010-1D950B8E-7623-4AAF-833F-F06D00C561FCQ33396344-D2E69CD6-0006-492F-A2E2-D959898A050AQ33398293-56F206D7-2F08-4C52-86BC-EA18ED7991A8Q33399411-5810A580-C6B8-46FA-AFA3-586351993BE4Q33401049-002CA85B-0F67-4175-B94D-73313DCEE6E7Q33401369-BAEF99C5-073A-4A1D-90CB-E64562B98B34Q33401647-5379D574-55EE-49C0-96D6-0C20911AD397
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Recent advances in thrombotic thrombocytopenic purpura.
@ast
Recent advances in thrombotic thrombocytopenic purpura.
@en
type
label
Recent advances in thrombotic thrombocytopenic purpura.
@ast
Recent advances in thrombotic thrombocytopenic purpura.
@en
prefLabel
Recent advances in thrombotic thrombocytopenic purpura.
@ast
Recent advances in thrombotic thrombocytopenic purpura.
@en
P2093
P1476
Recent advances in thrombotic thrombocytopenic purpura.
@en
P2093
J Evan Sadler
James N George
Joel L Moake
Toshiyuki Miyata
P304
P356
10.1182/ASHEDUCATION-2004.1.407
P577
2004-01-01T00:00:00Z